XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.2
OVERVIEW, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Jul. 31, 2023
Jul. 31, 2023
Oct. 31, 2022
Jul. 31, 2022
Oct. 31, 2021
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents          
Cash and cash equivalents $ 1,329 $ 1,329 $ 1,053    
Restricted Cash 3 3 3    
Cash, cash equivalents, restricted cash and restricted cash equivalents 1,332 1,332 1,056 $ 1,073 $ 1,490
Operating Leases          
Right-of-Use Asset $ 166 $ 166 $ 150    
Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Other assets Other assets Other assets    
Operating lease liability $ 178 $ 178 $ 152    
Operating Lease Liability, Statement of Financial Position [Extensible Enumeration] Other accrued liabilities, Other long-term liabilities Other accrued liabilities, Other long-term liabilities Other accrued liabilities, Other long-term liabilities    
Fair Value of Financial Instruments          
Carrying Value of Senior Notes $ 2,134 $ 2,134 $ 2,133    
Variable Interest Entity          
Assets 10,675 10,675 10,532    
Resolution Bioscience, Inc.          
Variable Interest Entity [Line Items]          
Long-Lived Asset Impairment Charge 270 270      
Quoted Prices in Active Markets for Identical Assets (Level 1) | Senior Notes          
Fair Value of Financial Instruments          
Fair Value of Senior Notes 1,830 1,830 1,754    
Variable Interest Entity, Not Primary Beneficiary [Member]          
Variable Interest Entity          
Assets $ 77 $ 77 $ 87